Journal article · 2009 · Open access
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
Cochrane Database of Systematic Reviews, CD006324 · Published 3 July 2009 · DOI 10.1002/14651858.cd006324.pub2
In brief
“Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia” is a 2009 journal article by Andrea Cipriani and 2 co-authors, published in Cochrane Database of Systematic Reviews. OpenAlex counts 95 citations as of 20 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).
- Citations
- 95
- Most cited in
- 2017 (5)
- References
- 50
- Authors
- 3
Abstract
BACKGROUND: Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two thirds of people still have persistent positive symptoms despite clozapine monotherapy of adequate dosage and duration. The need to provide effective therapeutic interventions to patients who do not have an optimal response to clozapine is the most common reason for simultaneously prescribing a second antipsychotic drug in combination with clozapine. OBJECTIVES: To determine the efficacy and tolerability of various clozapine combination strategies with antipsychotics in people with treatment resistant schizophrenia. SEARCH STRATEGY: We searched the Cochrane Schizophrenia Group Trials Register (March 2008) and MEDLINE (up to November 2008). We checked reference lists of all identified randomised controlled trials and requested pharmaceutical companies marketing investigational products to provide relevant published and unpublished data. SELECTION CRITERIA: We included only randomised controlled trials recruiting people of both sexes, aged 18 years or more, with a diagnosis of treatment-resistant schizophrenia (or related disorders) and comparing clozapine plus another antipsychotic drug with clozapine plus a different antipsychotic drug. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and resolved disagreement by discussion with third member of the team. When insufficient data were provided, we contacted the study authors. MAIN RESULTS: Three small (range of number of participants 28 to 60) randomised controlled trials were included in the review. Even though results from individual studies did not find that one combination strategy is better than the others, the methodological quality of included studies was too low to allow authors to use the collected data to answer the research question correctly. AUTHORS' CONCLUSIONS: In this review we considered the risk of bias too high because of the poor quality of the retrieved information (small sample size, heterogeneity of comparisons, flaws in the design, conduct and analysis). Although clinical guidelines recommend a second antipsychotic in addition to clozapine in partially responsive patients with schizophrenia, the present systematic review was not able to show if any particular combination strategy was superior to the others. New, properly conducted, randomised controlled trials independent from the pharmaceutical industry need to recruit many more patients to give a reliable estimate of effect or of no effect of antipsychotics as combination treatment with clozapine in patients who do not have an optimal response to clozapine monotherapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Cipriani, A., Boso, M., & Barbui, C. (2009). Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database of Systematic Reviews, CD006324. https://doi.org/10.1002/14651858.cd006324.pub2
MLA 9
Cipriani, Andrea, et al. “Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.” Cochrane Database of Systematic Reviews, no. 3, 2009, p. CD006324. https://doi.org/10.1002/14651858.cd006324.pub2.
Chicago
Cipriani, Andrea, Marianna Boso, and Corrado Barbui. 2009. “Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.” Cochrane Database of Systematic Reviews (3): CD006324. https://doi.org/10.1002/14651858.cd006324.pub2.
Harvard
Cipriani, A., Boso, M. and Barbui, C. (2009) ‘Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia’, Cochrane Database of Systematic Reviews, p. CD006324. doi:10.1002/14651858.cd006324.pub2.
IEEE
A. Cipriani, M. Boso, and C. Barbui, “Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia,” Cochrane Database of Systematic Reviews, no. 3, p. CD006324, 2009, doi: 10.1002/14651858.cd006324.pub2.
BibTeX
@article{cipriani2009clozapine,
title = {{Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia}},
author = {Cipriani, Andrea and Boso, Marianna and Barbui, Corrado},
journal = {Cochrane Database of Systematic Reviews},
year = {2009},
number = {3},
pages = {CD006324},
doi = {10.1002/14651858.cd006324.pub2},
url = {https://doi.org/10.1002/14651858.cd006324.pub2}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 5 | |
| 2018 | 3 | |
| 2019 | 5 | |
| 2020 | 3 | |
| 2021 | 4 | |
| 2022 | 4 | |
| 2023 | 4 | |
| 2024 | 2 | |
| 2025 | 3 | |
| 2026 | 1 |
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- clozapine
- treatment-resistant schizophrenia
- antipsychotic polypharmacy
- treatment response
- tolerability
- risk of bias
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Cipriani, A., Boso, M., & Barbui, C. (2009). Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database of Systematic Reviews, CD006324. https://doi.org/10.1002/14651858.cd006324.pub2
How many times has this paper been cited?
95 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.
Who wrote this paper?
Andrea Cipriani, Marianna Boso, Corrado Barbui.
What is the DOI of this paper?
10.1002/14651858.cd006324.pub2, permanently at https://doi.org/10.1002/14651858.cd006324.pub2. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.